Journal article
Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms
Abstract
Androgen deprivation therapy (ADT) is frequently used for the treatment of advanced prostate cancer. ADT is associated with numerous side effects related to its mode of action, namely the suppression of testosterone to castrate levels. Recently, several large retrospective studies have also reported an increased risk of diabetes and cardiovascular disease in men receiving ADT, although these risks have not been confirmed by prospective …
Authors
Tivesten Å; Pinthus JH; Clarke N; Duivenvoorden W; Nilsson J
Journal
Urologic Oncology Seminars and Original Investigations, Vol. 33, No. 11, pp. 464–475
Publisher
Elsevier
Publication Date
November 2015
DOI
10.1016/j.urolonc.2015.05.030
ISSN
1078-1439